Literature DB >> 22385918

Predicting recurrence after radiotherapy in head and neck cancer.

Adrian C Begg1.   

Abstract

Head and neck squamous cell carcinoma (HNSCC) is the sixth most common cancer worldwide. Radiotherapy is a mainstay of treatment, either alone for early stage tumors or combined with chemotherapy for late stage tumors. An overall 5-year survival rate of around 50% for HNSCC demonstrates that treatment is often unsuccessful. Prediction of outcome is, therefore, aimed at sparing patients from ineffective and toxic treatments on the one hand, and indicating more successful treatment modalities on the other. Both functional and genetic assays have been developed to predict intrinsic radiosensitivity, hypoxia, and repopulation rate. Few, however, have shown consistent correlations with outcome across multiple studies. Messenger RNA and microRNA profiling show promise for predicting hypoxia, whereas epidermal growth factor receptor expression combined with other measures of tumor differentiation grade shows promise for predicting repopulation rate. Intrinsic radiosensitivity assays have not proven useful to date, although development of repair protein foci assays indicates promise from preclinical studies. Assays for cancer stem cell content have shown promise in several clinical studies. In addition, 2 assays showing robustness as predictors for outcome in HNSCC are human papilloma virus status and epidermal growth factor receptor expression. Neither these nor stem cell assays, however, can as yet reliably indicate alternative and better treatments for poor prognosis patients. It would be of great value to have assays that predict the benefit for an individual from combining new molecularly targeted agents with radiotherapy to increase response, in particular those that exploit tumor mutations to provide tumor specificity. Predictive assays are being developed for detecting defects in repair pathways for single- and double-strand DNA breaks, which should allow selection of drugs targeting the appropriate backup pathway, thus exploiting the concept of synthetic lethality. This is one of the most promising areas for prediction, both currently and in the future. Copyright Â
© 2012. Published by Elsevier Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22385918     DOI: 10.1016/j.semradonc.2011.12.002

Source DB:  PubMed          Journal:  Semin Radiat Oncol        ISSN: 1053-4296            Impact factor:   5.934


  23 in total

Review 1.  Predicting outcomes in radiation oncology--multifactorial decision support systems.

Authors:  Philippe Lambin; Ruud G P M van Stiphout; Maud H W Starmans; Emmanuel Rios-Velazquez; Georgi Nalbantov; Hugo J W L Aerts; Erik Roelofs; Wouter van Elmpt; Paul C Boutros; Pierluigi Granone; Vincenzo Valentini; Adrian C Begg; Dirk De Ruysscher; Andre Dekker
Journal:  Nat Rev Clin Oncol       Date:  2012-11-20       Impact factor: 66.675

Review 2.  Understanding the tumor microenvironment and radioresistance by combining functional imaging with global gene expression.

Authors:  Mark W Dewhirst; Jen-Tsan Chi
Journal:  Semin Radiat Oncol       Date:  2013-10       Impact factor: 5.934

3.  Salvage surgery for head and neck squamous cell carcinoma.

Authors:  Magis Mandapathil; Marion Roessler; Jochen A Werner; Carl E Silver; Alessandra Rinaldo; Alfio Ferlito
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-04-23       Impact factor: 2.503

4.  Oxygen and Perfusion Kinetics in Response to Fractionated Radiation Therapy in FaDu Head and Neck Cancer Xenografts Are Related to Treatment Outcome.

Authors:  Nimmi Ramanujam; Mark W Dewhirst; Fangyao Hu; Karthik Vishwanath; Joseph K Salama; Alaattin Erkanli; Bercedis Peterson; James R Oleson; Walter T Lee; David M Brizel
Journal:  Int J Radiat Oncol Biol Phys       Date:  2016-06-14       Impact factor: 7.038

5.  The Expression Profile, Clinical Application and Potential Tumor Suppressing Mechanism of hsa_circ_0001675 in Head and Neck Carcinoma.

Authors:  Yujie Cao; Dong Ye; Zhisen Shen; Zan Li; Qun Li; Hao Rong
Journal:  Front Oncol       Date:  2022-05-06       Impact factor: 5.738

6.  Equating salivary lactate dehydrogenase (LDH) with LDH-5 expression in patients with oral squamous cell carcinoma: An insight into metabolic reprogramming of cancer cell as a predictor of aggressive phenotype.

Authors:  Tajindra Singh Saluja; Anita Spadigam; Anita Dhupar; Shaheen Syed
Journal:  Tumour Biol       Date:  2015-11-15

7.  Early detection of recurrent disease by FDG-PET/CT leads to management changes in patients with squamous cell cancer of the head and neck.

Authors:  Lale Kostakoglu; Reza Fardanesh; Marshall Posner; Peter Som; Srikar Rao; Eunice Park; John Doucette; Evan G Stein; Vishal Gupta; Krzysztof Misiukiewicz; Eric Genden
Journal:  Oncologist       Date:  2013-09-13

Review 8.  EMT, CTCs and CSCs in tumor relapse and drug-resistance.

Authors:  Abhisek Mitra; Lopa Mishra; Shulin Li
Journal:  Oncotarget       Date:  2015-05-10

9.  Investigation of radiation-induced transcriptome profile of radioresistant non-small cell lung cancer A549 cells using RNA-seq.

Authors:  Hee Jung Yang; Namshin Kim; Ki Moon Seong; HyeSook Youn; BuHyun Youn
Journal:  PLoS One       Date:  2013-03-22       Impact factor: 3.240

10.  Expression of miR-296-5p as predictive marker for radiotherapy resistance in early-stage laryngeal carcinoma.

Authors:  Danielle Maia; Ana Carolina de Carvalho; Maria Aderuza Horst; André Lopes Carvalho; Cristovam Scapulatempo-Neto; Andre Luiz Vettore
Journal:  J Transl Med       Date:  2015-08-12       Impact factor: 5.531

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.